Melissa Lee

Host of @CNBCFastMoney and @CNBCOvertime on @CNBC

[Melissa Lee @MelissaLeeCNBC]

ICYMI- our latest investigation:
Chinese lidar maker with Nvidia ties accused of being cyber risk for U.S. https://t.co/BpXAYNFvBn

[CNBC's Fast Money @CNBCFastMoney]

#NEW @CMEGroup to sue CFTC over the approval of perpetual futures as soon as tomorrow.

Outgoing CEO Terry Duffy speaks to Fast Money exclusively on the lawsuit and his decision to retire. https://t.co/g6Kjz4c5bC

[CNBC's Fast Money @CNBCFastMoney]

Americans are struggling to afford their medications — & one industry claims to have the answer.

@MelissaLeeCNBC investigates how the industry is importing drugs through unauthorized channels, a practice federal officials say is illegal and risky.
https://t.co/5X25TnGThS

[Melissa Lee @MelissaLeeCNBC]

Thrilled to share our latest investigative documentary @scottzamost @TortorelliPaige

[CNBC @CNBC]

Cheaper medicines, free beach trips: U.S. health plans tap prescriptions that feds say are illegal https://t.co/GMTZ4OvrMN

[CNBC's Fast Money @CNBCFastMoney]

🎁You’re invited to Fast Money LIVE: Trading the
Holidays, a festive experience at the Nasdaq MarketSite on Thurs. Dec. 11!

Join @MelissaLeeCNBC @GuyAdami @timseymour @karenfinerman @grassosteve @Bonawyn Dan Nathan & hear their top 2026 ideas

RSVP here:
https://t.co/1vUxEcNjBe

[Scott Zamost @scottzamost]

Honored that our investigation “Ozempic Underworld: The Black Market Of Obesity Drugs” is a @LoebAwards finalist. @MelissaLeeCNBC @onlyyoontv

[CNBC's Fast Money @CNBCFastMoney]

Fast Money LIVE is coming back June 5!

Get a behind the scenes look to America's post-market show, watch the show in person and meet @MelissaLeeCNBC @GuyAdami @timseymour @karenfinerman & Dan Nathan!

Tickets are limited. Get yours today: https://t.co/iMdezUMeaK

[Melissa Lee @MelissaLeeCNBC]

Catch Porter and Vinny of Seawolf Capital on @CNBCFastMoney tonight! (They were up 66% last year!)

[Guy Adami @GuyAdami]

The Big Short panel moderated by ⁦@MelissaLeeCNBC⁩ here at Global Alts ⁦@iconnections_io⁩

[Melissa Lee @MelissaLeeCNBC]

This event is sold out! But stay tuned for future live events!

[Melissa Lee @MelissaLeeCNBC]

Come experience @CNBCFastMoney LIVE! Limited seats are available!

At the NASDAQ, Thursday, Feb. 27th. Visit https://t.co/BZPXLjSkmn for more details and to get your tickets today!!

[Melissa Lee @MelissaLeeCNBC]

We have a handful of tickets left!

[CNBC's Fast Money @CNBCFastMoney]

Calling Fast Money fans for the ultimate experience!

Join us Feb. 27 for our live show, a cocktail hour with @MelissaLeeCNBC @karenfinerman @timseymour @grassosteve @GuyAdami, Dan Nathan and more!

For more details and tickets: https://t.co/fOS758CyJx

[Melissa Lee @MelissaLeeCNBC]

Come experience @CNBCFastMoney LIVE! Limited seats are available!

At the NASDAQ, Thursday, Feb. 27th. Visit https://t.co/BZPXLjSkmn for more details and to get your tickets today!!

[Melissa Lee @MelissaLeeCNBC]

@GuyAdami Mech

[Melissa Lee @MelissaLeeCNBC]

$ALT +20%. See what the CEO has to say about partnerships and being a potential takeout target ⤵️

[CNBC's Fast Money @CNBCFastMoney]

Another obesity drug competitor?

@AltimmuneInc CEO Vipin Garg breaks down what's next for his company's experimental obesity drug pemvidutide, and what differentiates it from the rest of the field $ALT

https://t.co/glItwNlsNw

[Melissa Lee @MelissaLeeCNBC]

Using AI to uncover potential shorts… fascinating discussion with Hudson Labs CEO!

[CNBC's Fast Money @CNBCFastMoney]

Financial AI platform @HudsonLabs first flagged risks at $SMCI in 2022 and again in January 2024.

CEO @KrisBennatti discusses how the software detects risks and what it found out about the company.

[Melissa Lee @MelissaLeeCNBC]

Watch our full investigation into counterfeit weight loss drugs!
On https://t.co/D0M7bzewyv and YouTube
https://t.co/1sNBJpOWnl

[Melissa Lee @MelissaLeeCNBC]

The investigation js live online now. Check it out!
Ozempic underworld: Inside the black market of obesity drugs @CNBC https://t.co/5VluoEnJDO

[Melissa Lee @MelissaLeeCNBC]

Excited to share this story tomorrow!

[CNBC @CNBC]

TOMORROW: A CNBC investigation finds that Novo Nordisk’s Ozempic and other wildly popular obesity drugs are being counterfeited and illegally diverted from other countries in open marketplaces online and shipped at cut rate prices to the U.S.

Tune into Squawk Box and https://t.co/LwXXuoVAyk at 8 a.m. on Wednesday to watch Ozempic Underworld: The Black Market of Obesity Drugs.

[CNBC's Fast Money @CNBCFastMoney]

.@VD718, @Seawolfcap and @dmoses34 of "Big Short" fame revisit the trades they shared on "Fast Money" in January and reveal their highest-conviction plays right now:

[CNBC's Fast Money @CNBCFastMoney]

"Big Short" traders @VD718, @Seawolfcap and @dmoses34 reunite!

The panel makes sense of market rotation, election odds and positioning now: